Publications:70
Accepting New Patients
Book an Appointment
About Me
Dr. Nikhil Waingankar joined Mount Sinai as a Urologist in 2016. After earning his medical degree from the University of Oklahoma College of Medicine, Dr. Waingankar completed his internship in General Surgery at Johns Hopkins. He then moved to North Shore Long Island Jewish Health System for his residency in Urology, where he served as Chief Resident during his final year. To complete his training, Dr. Waingankar completed his fellowship In Urologic Oncology at Fox Chase Cancer Center before earning his Masters of Science from UPenn. With his board certification by the American Board of Urology, Dr. Waingankar specializes in urologic oncology with expertise in open, laparoscopic, endoscopic, and robotic surgical techniques.
In addition to his clinical role, Dr. Waingankar serves as Assistant Professor of Vascular Surgery at The Icahn School of Medicine. He is also a member of the American Urological Association and the Society of Urologic Oncology. Throughout his career, Dr. Waingankar has authored several publications and book chapters, as well as given numerous presentations at national meetings.
Dr. Waingankar has conducted extensive research in health services. He is currently involved in research at the Institute for Healthcare Delivery Science with the Mount Sinai Deptartment of Population Health Science and Policy. His research team aims to examine the impacts of care intensity and variations in practice patterns on patient outcomes both at the national level and within The Mount Sinai Health System.
Language
Position
Hospital Affiliations
- Mount Sinai Queens
- The Mount Sinai Hospital
About Me
Dr. Nikhil Waingankar joined Mount Sinai as a Urologist in 2016. After earning his medical degree from the University of Oklahoma College of Medicine, Dr. Waingankar completed his internship in General Surgery at Johns Hopkins. He then moved to North Shore Long Island Jewish Health System for his residency in Urology, where he served as Chief Resident during his final year. To complete his training, Dr. Waingankar completed his fellowship In Urologic Oncology at Fox Chase Cancer Center before earning his Masters of Science from UPenn. With his board certification by the American Board of Urology, Dr. Waingankar specializes in urologic oncology with expertise in open, laparoscopic, endoscopic, and robotic surgical techniques.
In addition to his clinical role, Dr. Waingankar serves as Assistant Professor of Vascular Surgery at The Icahn School of Medicine. He is also a member of the American Urological Association and the Society of Urologic Oncology. Throughout his career, Dr. Waingankar has authored several publications and book chapters, as well as given numerous presentations at national meetings.
Dr. Waingankar has conducted extensive research in health services. He is currently involved in research at the Institute for Healthcare Delivery Science with the Mount Sinai Deptartment of Population Health Science and Policy. His research team aims to examine the impacts of care intensity and variations in practice patterns on patient outcomes both at the national level and within The Mount Sinai Health System.
Language
Position
Hospital Affiliations
- Mount Sinai Queens
- The Mount Sinai Hospital
Clinical Focus
- Adrenalectomy
- Adrenocortical Carcinoma
- Benign Prostatic Hyperplasia
- Bladder Cancer
- Bladder Stone
- Cystoscopy
- Elevated PSA
- Evaluation of Kidney Mass
- Hydronephrosis
Show More
Education
MD, uwasmc
Internship, Surgery (General Surgery)
Johns Hopkins Hospital
Residency, Urology
North Shore Long Island Jewish Health System
Fellowship, Urologic Oncology
Fox Chase Cancer Center
Certifications
American Board of Urology
Research
Cancer
Locations
Insurance Information
Accepted insurance may vary by the doctor’s office location. Please contact the office directly to obtain the most up-to-date insurance information.
Patients with Cigna Medicare Advantage or Humana Medicare Advantage insurance: Please read this important message before booking to find out if out-of-network costs may apply to your next visit.
- Mount Sinai Doctors - Astoria25-20 30th Ave, 5th Floor, Astoria, NY, 11102
Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).
Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.
Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.
Publications
Selected Publications
- Efficacy of Bacillus Calmette-Guérin compared to sequential gemcitabine and docetaxel in Ta high-grade non-muscle invasive bladder cancer. Ahmed Eraky, Brenda Hug, Reuben Ben-David, Kaushik P. Kolanukuduru, Nikhil Waingankar, Kyrollis Attalla, Peter Wiklund, Reza Mehrazin, John P. Sfakianos. World Journal of Urology
- Pheochromocytoma and Paragangliomas: Current Management Strategies. Reuben Ben-David, Ahmed Eraky, Reza Mehrazin, Nikhil Waingankar. Urologic Clinics of North America
- Differential response of low- and high-grade intermediate-risk non-muscle-invasive bladder cancer to bacillus Calmette-Guérin and gemcitabine-docetaxel therapy. Ahmed Eraky, Kaushik P. Kolanukuduru, Brenda Hug, Reuben Ben-David, Kyrollis Attalla, Nikhil Waingankar, Peter Wiklund, Reza Mehrazin, John P. Sfakianos. Urologic Oncology: Seminars and Original Investigations
Patient Experience Star Ratings and Comments
The Patient Experience Star Rating reflects our patients’ perception of how well their Mount Sinai provider communicated with them during an office visit. The Star Rating is based on patient responses to three questions on a patient experience survey, a standardized questionnaire sent to verified patients and distributed by a third party vendor, Press Ganey. Responses are measured on a scale of 1 to 5, with 5 being the best score.
Care Provider’s Explanation
Care Provider’s Concern
Likelihood to Recommend Care Provider
Industry Relationships
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.
Dr. Waingankar has not yet completed reporting of Industry relationships.
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.
Dr. Waingankar has not yet completed reporting of Industry relationships.
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.